SEC Filing Summary: ADVENTRX Pharmaceuticals, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by ADVENTRX Pharmaceuticals, Inc. on June 21, 2012, reporting events from its 2012 Annual Meeting of Stockholders held on June 20, 2012. The filing details the results of shareholder votes regarding director elections and the ratification of the independent auditor. Note: The request metadata references "Savara Inc," but the filing text explicitly identifies the registrant as ADVENTRX Pharmaceuticals, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Election of Directors: Four nominees were elected to serve until the next annual meeting.
- Brian M. Culley: 11,904,371 For; 647,235 Against; 219,473 Abstain.
- Jack Lief: 11,534,421 For; 1,009,830 Against; 226,828 Abstain.
- David A. Ramsay: 11,542,279 For; 1,005,922 Against; 222,878 Abstain.
- Lewis J. Shuster: 11,538,031 For; 1,006,180 Against; 226,868 Abstain.
All nominees received significant broker non-votes (22,437,754 each).
- Ratification of Auditor: The appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2012, was ratified.
- Votes: 34,696,766 For; 474,146 Against; 37,921 Abstain; 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the current corporate name and ticker symbol, as the filing identifies the company as ADVENTRX Pharmaceuticals, Inc., not Savara Inc.
- Confirm the tenure and background of the newly elected directors (Culley, Lief, Ramsay, Shuster).
- Review the full Annual Report (Form 10-K) for the fiscal year ended December 31, 2011, to obtain financial metrics absent from this 8-K.
- Check for any subsequent filings regarding the company's financial status or potential name changes.